je.st
news
Tag: vaccine
New HPV vaccine from Merck strengthens cervical cancer protection
2014-12-10 22:43:17| Biotech - Topix.net
The drugmaker Merck & Co. Inc. has received approval for an updated version of its Gardasil vaccine that protects against an additional five strains of the virus that causes most cases of cervical cancer.
Tags: protection
cancer
vaccine
cervical
FLEXCombo Swine Vaccine Soon Available in 50-dose Presentation
2014-12-10 17:58:51| National Hog Farmer
Boehringer Ingelheim Vetmedica Inc. (BIVI) makes it easier for producers and veterinarians to vaccinate pigs against porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae with a single injection of FLEXcombo. FLEXcombo, a member of the FLEX Family of vaccines, will be available in a new 50-dose presentation starting January, in addition to a 250-dose presentation, giving producers and veterinarians a choice of sizes that best fit their operations and number of pigs to vaccinate, with less wasted vaccine. read more
Tags: presentation
vaccine
swine
vaccine swine
Ebola buster booster vaccine starts first trials in Oxford
2014-12-04 15:35:33| Biotech - Topix.net
Scientists at Oxford University have launched the first clinical tests of a new Ebola vaccine approach, using a booster developed by Denmark's Bavarian Nordic that may improve the effects of a shot from GlaxoSmithKline. Thirty healthy volunteers in Britain who have already received the experimental Ebola vaccine being developed by GSK and the US National Institutes of Health will get the booster shot, researchers said on Thursday.
Tags: starts
oxford
trials
booster
BIVI FLEXCombo Swine Vaccine Available January
2014-12-03 01:00:00| ThePigSite - Industry News
GERMANY - Boehringer Ingelheim Vetmedica, Inc. (BIVI) makes it easier for producers and veterinarians to vaccinate pigs against porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae with a single injection of FLEXcombo®.
Tags: january
vaccine
swine
bivi
Experimental Ebola Vaccine Shows Promise: Researchers
2014-12-02 11:35:48| Biotech - Topix.net
An experimental Ebola virus vaccine tested at the National Institutes of Health in Bethesda shows promising results, and has medical researchers planning to accelerate the pace of human trials. The vaccine to prevent Ebola virus disease produced antibodies in all 20 healthy adults who received it in a clinical trial.
Tags: shows
experimental
researchers
promise
Sites : [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] next »